In vitro activity of caspofungin against Candida albicans biofilms

被引:232
作者
Bachmann, SP
VandeWalle, K
Ramage, G
Patterson, TF
Wickes, BL
Graybill, JR
López-Ribot, JL
机构
[1] Univ Texas, Hlth Sci Ctr, S Texas Ctr Biol Med, Dept Med,Div Infect Dis, San Antonio, TX 78245 USA
[2] Univ Texas, Hlth Sci Ctr, Dept Microbiol, San Antonio, TX 78245 USA
关键词
D O I
10.1128/AAC.46.11.3591-3596.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Most manifestations of candidiasis are associated with biofilm formation on biological or inanimate surfaces. Candida albicans biofilms are recalcitrant to treatment with conventional antifungal therapies. Here we report on the activity of caspofungin, a new semisynthetic echinocandin, against C. albicans biofilms. Caspofungin displayed potent in vitro activity against sessile C. albicans cells within biofilms, with MICs at which 50% of the sessile cells were inhibited well within the drug's therapeutic range. Scanning electron microscopy and confocal scanning laser microscopy were used to visualize the effects of caspofungin on preformed C. albicans biofilms, and the results indicated that caspofungin affected the cellular morphology and the metabolic status of cells within the biofilms. The coating of biomaterials with caspofungin had an inhibitory effect on subsequent biofilm development by C. albicans. Together these findings indicate that caspofungin displays potent activity against C. albicans biofilms in vitro and merits further investigation for the treatment of biofilm-associated infections.
引用
收藏
页码:3591 / 3596
页数:6
相关论文
共 42 条
  • [1] Efficacy of the echinocandin caspofungin against disseminated aspergillosis and candidiasis in cyclophosphamide-induced immunosuppressed mice
    Abruzzo, GK
    Gill, CJ
    Flattery, AM
    Kong, L
    Leighton, C
    Smith, JG
    Pikounis, VB
    Bartizal, K
    Rosen, H
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (09) : 2310 - 2318
  • [2] [Anonymous], AIDS READ
  • [3] In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp.
    Arikan, S
    Lozano-Chiu, M
    Paetznick, V
    Rex, JH
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (01) : 245 - 247
  • [4] In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates
    Arikan, S
    Lozano-Chiu, M
    Paetznick, V
    Rex, JH
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (01) : 327 - 330
  • [5] In vitro activity of caspofungin (MK-0991) against Candida albicans clinical isolates displaying different mechanisms of azole resistance
    Bachmann, SP
    Patterson, TF
    López-Ribot, JL
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (06) : 2228 - 2230
  • [6] Baillie GS, 1999, METHOD ENZYMOL, V310, P644
  • [7] Effect of growth rate on resistance of Candida albicans biofilms to antifungal agents
    Baillie, GS
    Douglas, LJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (08) : 1900 - 1905
  • [8] BANERJEE SN, 1991, AM J MED, V91, P865
  • [9] Barchiesi F, 1999, EUR J CLIN MICROBIOL, V18, P302
  • [10] In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872)
    Bartizal, K
    Gill, CJ
    Abruzzo, GK
    Flattery, AM
    Kong, L
    Scott, PM
    Smith, JG
    Leighton, CE
    Bouffard, A
    Dropinski, JF
    Balkovec, J
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (11) : 2326 - 2332